Bexorg is an innovative biotech startup dedicated to revolutionizing CNS drug discovery through its proprietary BrainEx platform, which enables preclinical studies on human and porcine brains. By integrating advanced wet-lab experiments with AI/ML-driven drug discovery via its XO Digital platform, Bexorg is at the forefront of transforming the understanding and treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's. The company is committed to identifying novel therapeutic targets and advancing drug discovery through collaborative and groundbreaking research. With a focus on scientific excellence, Bexorg fosters a dynamic work environment that offers abundant opportunities for career growth in the rapidly evolving biotech field.